Facility #1

Austin, Texas 78757

0 studies enrolling now · 6 studies all time

What they study most

Alzheimer's Disease, Breast Neoplasm, Hepatocellular Carcinoma (HCC), Insomnia Disorder, Partial-Onset or Primary Generalized Tonic-Clonic Seizures

Studies at this site

• A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease — Completed
• Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures — Completed
• Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Participants With Metastatic Triple-Negative Breast Cancer (mTNBC) — Completed
• A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma — Completed
• A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease — Stopped early
• Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2) — Completed